Stay updated on BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial page.

Latest updates to the BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial page
- Check5 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check12 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check19 days agoChange DetectedThe page now displays a 403 Forbidden message and a Home link instead of the study record content.SummaryDifference0.5%

- Check33 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, indicating access to the study record is blocked. This reflects an access/availability change rather than a substantive update to the page content.SummaryDifference17%

- Check54 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6 on the study page, reflecting the latest documentation version. This change does not alter study details or results.SummaryDifference0.0%

- Check61 days agoChange DetectedA new entry '2017 ( U.S. NIH Grant/Contract )' was added under the study's other identifiers, indicating NIH funding for the trial.SummaryDifference0.0%

Stay in the know with updates to BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial page.